跳至主要内容
临床试验/ISRCTN27745631
ISRCTN27745631已完成不适用

Acetylsalicylic acid as an adjuvant therapy for schizophrenia

niversity Medical Centre Utrecht (UMCU) (Netherlands)0 个研究点目标入组 80 人开始时间: 2005年5月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Schizophrenia, schizo-affective disorder, schizofreniform disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (for a maximum of 5 years) (as of 03/06/2008 this has been updated to a maximum of 10 years)
  • 2. Aged 18 - 55 years
  • 4. Minimum score of 60 on Positive and Negative Syndrome Scale (PANSS)
  • 5. Minimum 2 x a score of minimum 4 on PANSS

排除标准

  • 1. No contra-indication for acetylsalicylic acid
  • 2. No hypersensitivity to acetylsalicylic acid or pantoprazole
  • 3. No significant somatic illness
  • 4. No chronic use of a non-steroidal anti-inflammatory drug (NSAID)
  • 5. No use of corticosteroids
  • 6. Not pregnant
  • 7. No drug dependency
  • 8. Informed consent obtained

研究者

发起方
niversity Medical Centre Utrecht (UMCU) (Netherlands)

相似试验